Sawyer & Company Inc lessened its holdings in shares of Cardinal Health, Inc. (NYSE:CAH – Get Rating) by 66.2% in the 4th quarter, Holdings Channel reports. The fund owned 495 shares of the company’s stock after selling 970 shares during the quarter. Sawyer & Company Inc’s holdings in Cardinal Health were worth $38,000 at the end of the most recent reporting period.
Other large investors also recently bought and sold shares of the company. BOK Financial Private Wealth Inc. purchased a new stake in Cardinal Health during the 3rd quarter valued at about $28,000. McElhenny Sheffield Capital Management LLC purchased a new stake in Cardinal Health during the 4th quarter valued at about $36,000. Capital Advisors Ltd. LLC grew its stake in Cardinal Health by 29.5% during the 3rd quarter. Capital Advisors Ltd. LLC now owns 589 shares of the company’s stock valued at $39,000 after acquiring an additional 134 shares in the last quarter. EverSource Wealth Advisors LLC grew its stake in Cardinal Health by 422.0% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 642 shares of the company’s stock valued at $43,000 after acquiring an additional 519 shares in the last quarter. Finally, JDM Financial Group LLC purchased a new stake in Cardinal Health during the 4th quarter valued at about $47,000. Hedge funds and other institutional investors own 88.93% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts recently issued reports on the stock. StockNews.com initiated coverage on shares of Cardinal Health in a research note on Thursday. They set a “strong-buy” rating for the company. UBS Group increased their price target on shares of Cardinal Health from $78.00 to $91.00 and gave the company a “buy” rating in a research note on Tuesday, January 31st. Robert W. Baird raised shares of Cardinal Health from a “neutral” rating to an “outperform” rating and increased their price target for the company from $87.00 to $94.00 in a research note on Friday, February 3rd. Morgan Stanley increased their price target on shares of Cardinal Health from $86.00 to $90.00 and gave the company an “overweight” rating in a research note on Friday, February 3rd. Finally, Credit Suisse Group increased their price target on shares of Cardinal Health from $89.00 to $92.00 and gave the company a “neutral” rating in a research note on Friday, February 3rd. Seven equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $80.64.
Cardinal Health Stock Performance
Cardinal Health (NYSE:CAH – Get Rating) last posted its quarterly earnings data on Thursday, February 2nd. The company reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.13 by $0.19. The firm had revenue of $51.47 billion during the quarter, compared to analysts’ expectations of $50.03 billion. Cardinal Health had a negative net margin of 0.66% and a negative return on equity of 101.28%. The firm’s quarterly revenue was up 13.2% on a year-over-year basis. During the same quarter last year, the company posted $1.27 EPS. Research analysts forecast that Cardinal Health, Inc. will post 5.42 earnings per share for the current fiscal year.
Cardinal Health Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Saturday, April 15th. Shareholders of record on Monday, April 3rd will be issued a dividend of $0.4957 per share. The ex-dividend date is Friday, March 31st. This represents a $1.98 dividend on an annualized basis and a yield of 2.85%. Cardinal Health’s dividend payout ratio (DPR) is presently 36.33%.
Cardinal Health Profile
Cardinal Health, Inc is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency.
Featured Articles
- Get a free copy of the StockNews.com research report on Cardinal Health (CAH)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Get Rating).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.